Catalysts for $PFE

PFIZER INC earnings

PFIZER INC earnings

PFIZER INC earnings

Pfizer Inc — PF-08046032 (Phase I Trial Completion)

Clindamycin Phosphate Injection shortage — Pfizer Inc.

Palbociclib Capsule shortage — Pfizer Inc.

Methotrexate Sodium Injection shortage — Hospira, Inc., a Pfizer Company

Dexmedetomidine Hydrochloride Injection shortage — Pfizer Inc.

Methylprednisolone Acetate Injection shortage — Pfizer Inc.

Penicillin G Benzathine Injection shortage — Pfizer Inc.

Methylprednisolone Acetate Injection shortage — Par Health, USA LLC

METHYLPREDNISOLONE — FDA approval

UNIVERSITY OF NEBRASKA LINCOLN — The matrin3-CAR-thrombin axis in hepatic inflammation and fibrosis

CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval

CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approval

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval

ELREXFIO (ELRANATAMAB) — FDA approval

NURTEC ODT (RIMEGEPANT SULFATE) — FDA approval

XELJANZ (TOFACITINIB CITRATE) — FDA approval

XELJANZ XR (TOFACITINIB CITRATE) — FDA approval

ELREXFIO (ELRANATAMAB) — FDA approval

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)